Sign In
Buy CPRX
$31.49
+0 (+0%)
At Close: Jul 31, 2026
Best Value Stocks to Buy for March 31st
05:00am, Tuesday, 31'st Mar 2026
CPRX, STRT and BP made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 31st, 2026.
Wall Street Analysts Predict a 45.3% Upside in Catalyst (CPRX): Here's What You Should Know
10:55am, Monday, 30'th Mar 2026
The mean of analysts' price targets for Catalyst (CPRX) points to a 45.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analyst
Catalyst (CPRX) Down 2.5% Since Last Earnings Report: Can It Rebound?
12:32pm, Friday, 27'th Mar 2026
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock?
10:41am, Friday, 20'th Mar 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CPRX vs. UTHR: Which Stock Is the Better Value Option?
12:42pm, Wednesday, 18'th Mar 2026
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalyst Pharmaceutical (CPRX) and United Therapeutics (UTHR). But which of these two companies is the bes
Catalyst Pharmaceuticals Touts Firdapse Growth, Agamree Traction as Fycompa Faces Generics
02:02am, Monday, 16'th Mar 2026
Catalyst Pharmaceuticals (NASDAQ: CPRX) highlighted continued growth in its rare disease portfolio and outlined efforts to expand patient identification and penetration for its lead product during a r
Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
05:40pm, Tuesday, 10'th Mar 2026
Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Geopolitical Volatility Boosts Value Investing: 4 Low-PEG Picks
03:01pm, Tuesday, 10'th Mar 2026
Market volatility is reviving value hunts. AL, NESR, CPRX and JBTM stand out with low PEG metrics and solid growth outlooks after passing strict value screens.
Choreo LLC Buys Shares of 20,895 Catalyst Pharmaceuticals, Inc. $CPRX
03:55am, Saturday, 07'th Mar 2026
Choreo LLC purchased a new position in Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi
How Much Upside is Left in Catalyst (CPRX)? Wall Street Analysts Think 43.34%
10:55am, Friday, 06'th Mar 2026
The consensus price target hints at a 43.3% upside potential for Catalyst (CPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
CORAL GABLES, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and
All You Need to Know About Catalyst (CPRX) Rating Upgrade to Strong Buy
01:01pm, Wednesday, 04'th Mar 2026
Catalyst (CPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stock to Buy for March 4th
11:01am, Wednesday, 04'th Mar 2026
BTSG, XP and CPRX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 4, 2026.
Are Investors Undervaluing Catalyst Pharmaceuticals (CPRX) Right Now?
10:41am, Wednesday, 04'th Mar 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Best Value Stocks to Buy for March 4th
10:06am, Wednesday, 04'th Mar 2026
CPRX and XP made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 4, 2026.
